Na Cocer Peptides bin rayt am 
27 dez bifo.
mכsul εn tisu ripa na kכr fysiolojikal prכsεs dεm we de mεnten mכtal fכnshכn, strכkchכral integriti, εn post-injuri fכnshכnal rεkכnstrכkshכn, we involv kכmpleks mεkanism dεm lεk sεl proliferashכn, εkstrasεlula matris (ECM) rimכdelin, angiojεnεsis, εn inflammatory maykro envayroment rεguleshכn. di ki sεnariכ dεm na dis fil-inklud di mכsul dεm we de gro, wund hεl, jכyn rεpa, εn sכpכt injuri rεkכvεshכn — de dip pan prεsis intavεnshכn dεm fכ sataylayt sεl aktibכshכn, fכnshכn fכ di fכblas, mεtabolism fכ di katilej matris, εn nyuromכskular jכnkshכn rεpa. Pεptida sכbstans dεm, wit dεn hεy bayolojikal aktiviti εn tכgεt spεsifisiti, kin spεshal mכdulet sεlyul signal path dεm, protεkt tisu rigεnεreshכn, εn inhεbit fibrosis, we de kכmכt as krichכ tul dεm fכ כvakom bכtlεk in tradishכnal ripa tεrapi dεm εn sho brayt aplikεshכn prכspεkt in sכpכt mεdisin, trauma כpεrayshכn, εn rijεneretiv mεdisin.
Figure 1 wan ovaviu fכ skel mכsul ripa fכlכ injuri we sho di tri fεz dεm fכ mכsul ripa. Sos: Sɛl ɛn Tisu Risach.
Di Kɔr Aplikeshɔn Ɛria dɛn
1. di mכsul dεm we de gro: fכ protεkt di mayosayt sεntesis εn inhibit katabolism
di pεptid sכbstans dεm de optimize di mכsul mas εn fכnshכn bay we dεn de rεgεl di anabolik εn katabolik path dεm.
Sataylayt sɛl aktiveshɔn ɛn proliferashɔn
di pεpti dεm we de rilis di gכt hכmon (εgz., CJC-1295) de aktibכt di gכt hכmon sekretagכg rεsεpכta dεm, we de mek di pituitary gכt hכmon rilis εn fכ mek insulin lεk gכt fכktכ-1 (IGF-1) sεntez. dis de aktibכt dכwnstrכm path dεm fכ indyuz sataylayt sεl dεm fכ transishכn frכm wan kwεs stet to wan proliferativ stet, we de aksεlεrat mayofibrillar protin sεntez. dis pεpti dεm de inhεbit di ubiquitin-proteasome sistεm aktiviti bak, we de ridyus di mכsul protin dεgradashכn, we de mek dεn patikyula fit fכ ol-rεlatεd, disyuz-indyus mכsul atrofi, εn post-εksεsayz mכsul ripa.
Adiposayt mεtabolism εn mכsul protεkshכn
sכm pεpti dεm (εgz., AOD 9604) de ridyus inflammatory fכktכ sekreshכn bitwin adiposyt dεm εn mayosayt dεm bay we dεn de aktibכt brawn adipos tisu tεmכjεnεsis εn wayt adipos brawn, we de impruv di mכsul maykro envayroment. di protεktiv ifekt we dεn gεt pan di mayosayt maytochכndrial fכnshכn de ridyus εksεsayz-indyus כksidεtiv dεmεj εn i de protεkt fכ taya rεkכvεshכn.
2. Wund Hiling: Multistage Rεgulεshכn fכ di Ripa Pכsεs
frכm di inflammatory rispכns to di tisu rimכdelin, pεptida sכbstans dεm de rεgεl di כl saykl fכ wund hεl.
Inflammatory fεz rεgulεshכn
di pεptayd dεm lεk TB 500 de inhibit pasmak nyutrofil aktibכshכn εn fri radikal rilis, we de ridyus inflammatory damej. dεn de promuot bak makrofag polarizeshכn tכwεd di anti-inflammatory M2 fεnotayp, aksεlεrayt di kliarεns fכ nεkrכtik tisu εn mek wan fayn maykro envayroment fכ ripa.
di antimaykrobial pεpti dεm (εgz., LL37) de kil di patכgens dεm dεn wan dεm εn de rεgεl di imyun sεl kεmotaksis, we de ridyus di risk fכ infεkshכn na di wund. di aktibכshכn we dεn de mek fכ di epidamal growth fכktכ rεsεpכta dεm de εnhans di kεratinosayt maygrεshכn kapasiti.
Proliferashɔn ɛn rimɔdelin faz prɔmoshɔn
di gεstrointestinal protεktiv pεpti dεm (εgz., BPC-157) de aktibכt vaskulεr εndoteyl gכt fכktכ (VEGF) εn fibroblast gכt fכktכ (FGF) signal, we de protεkt εndoteyl sεl proliferashכn εn niovaskulεrayzeshכn fכ aksεlεrat wund blכd saplai rεkכnstrכkshכn. dεn de upregulate di εksprεshכn fכ tayp I kolagen εn fibronectin bak, we de εnhans granulεshכn tisu strכng.
di pεptayd dεm lεk GHK-Cu, as kכpa ayכn kכriכ, de protεkt laysyl כksidayz aktiviti, aksεlεrayt kolagen fayba kכros-link εn machכ fכ impruv di tεnsil strכng fכ di ska tisu. di inhibishכn we dεn de inhibishכn fכ matris mεtaloproteinεz dεm de ridyus di ECM dεgradashכn we pasmak, we de mek ska haypaplasia nכ de.
Figure 2 Bayoaktiv pεptida dεm εn protin dεm de rεgεl di ROS famili di tεm we di fisiolכjik εn patכlayz prכsεs dεm de. Sos: Bayoaktiv pεptida dεm εn protin dεm fכ tisu ripa: maykro envayroment mכduleshכn, rεshכnal dεlivεri, εn klinik pכtεnshal (2024).
3. Jכyn Ripa: Kכtilaj Protεkshכn εn Sinovial Inflamεshכn Rεgulεshכn
we dεn aim fכ di artikulכr kכtilaj wear εn sinovitis, di pεptida sכbstans dεm de protεkt di kכndrכsayt dεm εn inhεbit fכ fכm.
Katilaj matris mentenɛns
di pεpti dεm we rilet to di kכndrכitin (εgz., Chonluten) de protεkt di kכndrכsayt sεntez fכ proteoglycan dεm εn tayp II kolagen, we de inhεbit di kכtilaj matris dεgradashכn εn delay di kכtilaj dεgεnεreshכn insay כstioarthritis. di upregulashכn fכ di riletid jin dεm de mεnten di kכndrכsayt fεnotayp, we de ridyus haypatrכfi εn kalsifikεshכn.
di pεpti dεm we de protεkt di kכtilaj (εgz., Cartalax) de inhεbit fכ proliferashכn pasmak fכ di fibroblast lεk sinoviosayt dεm (FLS) εn di pro-inflammatory fכktכ sekreshכn, we de εliviet di sinovial inflameshn-indyus kכtilaj eroshכn, we fayn fכ adjuvant tεrapi insay rεumatoid εn traumatik atraytis.
Sεl protεkshכn εn apoptosis inhibishכn
SS-31, we na maytochכndria-tכgεt pεptida, de εmbas insay di kכndrכsayt maytochכndrial mεmbran dεm, we de mεnten di mεmbran pכtεnshal stεbiliti εn ridyus כksidεtiv strεs-indyus apoptosis fכ protεkt di sכvayvεns fכ dip artikulכr kכtilaj sεl dεm.
4. Spɔt Injuri Rikɔvayshɔn: Aksɛleret Ripa ɛn Fɔnshɔnal Rikɔnstrɔkshɔn
fכ mכsul strεn, tεndon injuri, εn ligament tεar, pεptida sכbstans dεm de εnhans rεkכvri efyushכn bay we dεn de rεgεl di ripa sεl fכnshכn dεm εn ECM rimכdelin.
di tεndon/ligament ripa εnhansmεnt
sכm pεpti dεm (εgz., TB 500 fragmεnt) de protεkt di tεndon stεm sεl difrεns insay tεnosayt dεm, de upregulate di εksprεshכn fכ tenascin-C εn tεndonektin, de εnhans di כdalayn fכ kolagen fayba arenjmεnt, ridyus ska tisu fכmeshכn, εn impruv di mεkanikal prכpati dεm fכ di sayt dεm we injuri.
di pεptayd dεm lεk CJC-1295, tru di sכstayn gכt hכmon rilis, de protεkt sataylayt sεl maygrεshכn to injuri tεndon dεm, aksεlεrat kolagen fayba sεntesis εn sכt di rεkכvri saykl fכ sכpכt injuri dεm—patikul bεnεfit fכ atlet dεm fכ rihabiliteshכn kwik kwik wan.
Dɔn
di aplikeshכn fכ pεptida sכbstans dεm na di mכsul εn tisu ripa de mak wan tεrapi כpgrεd frכm 'pasiv ripa' to 'aktiv rigεnεreshכn.' bay we dεn de tכk bכt di kכr path dεm lεk sataylayt sεl aktibכshכn, ECM rimכdelin, angiojεnεsis, εn inflameshn rεguleshכn, dεn sכbstans dεm ya de bεlε anabolik εn katabolik mεtabolism insay mכsul growth, kכdכnayt mכltistej prכsεs dεm na wund hilin, protεkt di kכtilaj matris εn inhεbit inflameshn insay di joyn ripa, εn aksεlεrat fכnshכnal rεkכnstrכkshכn insay sכpכt injuri dεm—we de sho mכltidimεnshכnal mεkanik advantej dεm.
ƆL DI ATIKUL ƐN PRODƆKT INFƆMƐSHƆN WE DƐN GI NA DIS WƐBSAYT NA FƆ ƆL FƆ DI INFƆMƐSHƆN ƐN FƆ EDYUKESHƆN.
Di prɔdak dɛn we dɛn gi na dis wɛbsayt na fɔ in vitro risach nɔmɔ. in vitro risach (Latin: *in glas*, we min insay glas) dεn de du am ausayd mכtalman bכdi. Dɛn prɔdak ya nɔto famasitik, dɛn nɔ gɛt di aprɔval frɔm di US Food and Drug Administration (FDA), ɛn dɛn nɔ fɔ yuz dɛn fɔ protɛkt, trit, ɔ mɛn ɛni mɛrɛsin, sik, ɔ sik. Di lɔ nɔ gri fɔ mek dɛn put dɛn tin ya insay mɔtalman ɔ animal bɔdi ɛni we.
